Compare NCSM & XTNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | NCSM | XTNT |
|---|---|---|
| Founded | 2006 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oilfield Services/Equipment | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 97.3M | 86.2M |
| IPO Year | 2017 | N/A |
| Metric | NCSM | XTNT |
|---|---|---|
| Price | $38.70 | $0.59 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $1.50 |
| AVG Volume (30 Days) | 5.8K | ★ 189.3K |
| Earning Date | 03-09-2026 | 03-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 4.53 | 0.01 |
| Revenue | ★ $178,000,000.00 | $133,083,000.00 |
| Revenue This Year | $11.25 | $15.08 |
| Revenue Next Year | $7.76 | N/A |
| P/E Ratio | ★ $8.54 | $52.28 |
| Revenue Growth | 16.49 | ★ 16.88 |
| 52 Week Low | $23.89 | $0.34 |
| 52 Week High | $53.69 | $0.95 |
| Indicator | NCSM | XTNT |
|---|---|---|
| Relative Strength Index (RSI) | 46.24 | 38.97 |
| Support Level | $36.03 | $0.55 |
| Resistance Level | $40.10 | $0.65 |
| Average True Range (ATR) | 1.53 | 0.04 |
| MACD | -0.05 | 0.00 |
| Stochastic Oscillator | 50.00 | 31.36 |
NCS Multistage Holdings Inc is a provider of engineered products and support services that facilitate the optimization of oil and natural gas well construction, well completions and field development strategies. NCS provides its products and services to exploration and production companies for use in onshore wells, predominantly wells that have been drilled with horizontal laterals in unconventional oil and natural gas formations. The company's offering is its fracturing systems products and services, which enable efficient pinpoint stimulation: the process of individually stimulating each entry point into a formation targeted by an oil or natural gas well. It sell products and services in North America and in selected international markets.
Xtant Medical Holdings Inc is a medical technology company focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant systems to facilitate spinal fusion in complex spine, deformity and degenerative procedures. Its products are used by orthopedic spine surgeons and neurosurgeons to treat a variety of spinal disorders in the cervical, thoracolumbar, and interbody spine. The company's biomaterial products include OsteoSponge, OsteoSponge SC, OsteoSelect Plus DBM putty, OsteoWrap, and the line of 3Demin products, as well as other allografts. It generates a majority of its revenue from the U.S.